Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
2013 Standout
Cancer and Altered Metabolism: Potential Importance of Hypoxia-Inducible Factor and 2-Oxoglutarate-Dependent Dioxygenases
2011 StandoutNobel
Gastric cancer
2016 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Fluorinated nucleosides: Synthesis and biological implication
2008
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
2014 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Systematic Review: Patterns of Reflux-Induced Symptoms and Esophageal Endoscopic Findings in Large-Scale Surveys
2012
Clevudine: a potent inhibitor of hepatitis B virusin vitroandin vivo
2006
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
2020
Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1α and its significance
2003
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti‐viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
2008
Non-alcoholic fatty liver disease
2021 Standout
Role of the Hypoxia-Related Gene, JMJD1A, in Hepatocellular Carcinoma: Clinical Impact on Recurrence after Hepatic Resection
2011
The role of platelets in the pathogenesis of cerebral malaria
2009
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
2022
Clevudine myopathy in patients with chronic hepatitis B
2009
Chronic hepatitis B: Update 2009 #
2009 Standout
Platelets and the immune continuum
2011 Standout
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
2014
Global burden of liver disease: 2023 update
2023 Standout
Gastric cancer
2020 Standout
Immunizations in Chronic Liver Disease: What Should be Done and What is the Evidence
2012
Hidradenitis suppurativa
2020 Standout
Unmet needs and challenges in gastric cancer: The way forward
2014
The maternal womb
2011
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Synthesis and biological evaluation of helioxanthin analogues
2012
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
2011
Fluorine in medicinal chemistry
2007 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
2011
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016
2020
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Noncompetitive Inhibition of Hepatitis B Virus Reverse Transcriptase Protein Priming and DNA Synthesis by the Nucleoside Analog Clevudine
2013
Works of Kwon Yoo being referenced
Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without thrombocytopenia
2003
Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
2019
Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease
2020
An association between obesity and the prevalence of colonic adenoma according to age and gender
2007
The Clinicopathological Significance of Tissue Levels of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor in Gastric Cancer
2009
Clevudine Therapy for 24 Weeks Further Reduced Serum Hepatitis B Virus DNA Levels and Increased ALT Normalization Rates without Emergence of Viral Breakthrough than 12 Weeks of Clevudine Therapy
2007
A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B
2006
Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
2001
Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population‐based study
2018
Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study.
2001
The Prevalence and Clinical Characteristics of Reflux Esophagitis in Koreans and Its Possible Relation to Metabolic Syndrome
2009
Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo
2019
Emerging Need for Vaccination against Hepatitis A Virus in Patients with Chronic Liver Disease in Korea
2007